|
2025
|
P/S
|
Wearable medical devices for the subcutaneous administration of pharmaceutical preparations |
|
|
P/S
|
Downloadable computer software for providing medical information; Recorded computer application s... |
|
|
Invention
|
Method for the treatment of fibrotic-related disorder associated to ibd. The present invention re... |
|
2024
|
Invention
|
Hplc-based detection of flocculation agents in a protein sample.
The current application provide... |
|
|
Invention
|
Compounds for treatment of a hyperkinetic movement disorder. The invention relates to compounds o... |
|
|
Invention
|
Antibodies. The present invention provides in particular antibodies or antigen-binding fragments ... |
|
|
Invention
|
Cell culture processes. The present invention belongs to the field of the manufacture of recombin... |
|
|
Invention
|
Cell culture methods.
The present invention relates to the use of limited amounts of cysteine an... |
|
|
Invention
|
Knob domain proteins. The present invention provides an antigen-binding protein comprising a knob... |
|
|
Invention
|
Preparation of bridged pentacyclic imidazole derivatives as modulators of tnf activity, intermedi... |
|
|
Invention
|
Fused pentacyclic imidazole derivatives as modulators of tnf activity.
A compound of formula (I)... |
|
|
Invention
|
Mechanism of action.
The invention is in the field of TNF signalling. Compounds have been identi... |
|
|
Invention
|
Crystalline form. i.e.i.e. (7R,14R)-11-[2-(1-aminocyclobutyl)pyrimidin-5-yl]-1-(difluoromethoxy)-... |
|
|
Invention
|
Engineered aav capsid proteins. The present disclosure relates to an engineered capsid protein co... |
|
|
Invention
|
Novel nucleic acid targeting systems comprising rna-guided nucleases. The present invention provi... |
|
|
Invention
|
Anti-ige antibodies.
The present invention relates to the area of improved anti-IgE antibodies a... |
|
|
Invention
|
Rna-guided nucleases and nucleic acid targeting systems comprising such rna-guided nucleases. The... |
|
|
Invention
|
Treatment of autoimmune diseases. The present disclosure provides methods of treating a rheumatic... |
|
|
Invention
|
Antibodies comprising a polypeptide inserted in framework 3 region.
The present invention provid... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of neurology diseases.
Medical appar... |
|
|
Invention
|
Imidazotriazine derivatives as il-17 modulators. A compound of formula (I) as defined herein, or ... |
|
|
Invention
|
Imidazotriazine derivatives as il-17 modulators. NSS)-(4,4-Difluorocyclohexyl){3-[1-(2,2-difluoro... |
|
|
Invention
|
Imaging agents.
The present invention relates to radiolabelled 4-(furo[3,2-c]pyridin-4-yl) deriv... |
|
|
Invention
|
Gene therapy. The present invention relates to nucleic acid constructs comprising granulin (GRN) ... |
|
|
Invention
|
Minzasolmin for use in the treatment of parkinson's disease. The present invention relates to MIN... |
|
|
Invention
|
Method for host cell protein detection. The present invention provides method for the measurement... |
|
|
Invention
|
Tricyclic azepinone derivatives as system xc inhibitors. The present invention relates to a compo... |
|
|
Invention
|
Antibody molecules which bind il-17a and il-17f.
The invention relates to antibody molecules hav... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of neurology diseases |
|
2023
|
P/S
|
Downloadable computer software for analyzing information and data in the field of healthcare; Dow... |
|
|
Invention
|
Imidazotriazine derivatives as il-17 modulators. N-[(S)-(4,4-Difluorocyclohexyl){3-[4-(2,2-difluo... |
|
|
Invention
|
Imidazotriazine derivatives as il-17 modulators. NSbb] [1,2,4]triazin-6-yl }methyl]-4-methyl-1,2,... |
|
|
Invention
|
Treatment of fibromyalgia |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment
of neurology diseases. Medical appa... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment
of neurology diseases. Pharmaceutic... |
|
|
Invention
|
Combination of a gremlin-1 antagonist with an inhibitor of ras-raf-mek-erk signalling.
The prese... |
|
|
P/S
|
Providing information in the field of central nervous system diseases, seizures, and epilepsy |
|
|
P/S
|
educational and entertainment services, namely, a series of online non-downloadable videos in the... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of diseases and disorders of the per... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of immunological and neurological di... |
|
|
P/S
|
Pharmaceutical preparations and substances. |
|
|
P/S
|
Software applications for mobile devices for accessing medical and health information; software a... |
|
|
P/S
|
Downloadable mobile applications for facilitating online communications between patients and heal... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoi... |
|
|
P/S
|
Mobile apps. Administering medication reimbursement programs and
services. Charitable fundraisin... |
|
|
P/S
|
Providing a website featuring medical information |
|
|
Invention
|
Antimalarial hexahydropyrimidine analogues.
A series of 2-imino-6-methylhexahydropyrimidin-4-one... |
|
|
Invention
|
Fused benzazepine derivatives for use in the treatmetn of cancer and epilepsy. The present invent... |
|
|
P/S
|
Mobile applications. Medical care and analysis services related to patient treatment; providing h... |
|
2022
|
Invention
|
Method for detecting and/or quantifying crosslinks formed by transglutaminases.
The present inve... |
|
|
Invention
|
Method for the treatment of a scleroderma disease.
The present invention relates to an anti-tran... |
|
|
Invention
|
Method for the treatment of progressive chronic interstitial lung disease.
The present invention... |
|
|
Invention
|
Antimalarial hexahydropyrimidine derivatives.
The compounds of formula (I) as defined herein, be... |
|
|
Invention
|
Nucleic acid constructs, viral vectors and viral particles.
The present invention relates to a n... |
|
|
Invention
|
Formulations.
The invention relates to the field of pharmaceutical formulations. More particular... |
|
|
P/S
|
Providing a web site featuring medical information; Providing a website featuring medical informa... |
|
|
Invention
|
Anti-hla-g antibodies.
The present invention relates to antibodies directed against HLA-G and fo... |
|
|
P/S
|
Mobile apps. Administering medication reimbursement programs and
services. Charitable services, ... |
|
|
Invention
|
Imidazotriazine derivatives as il-17 modulators.
A series of substituted imidazo[1,2-b][1,2,4]tr... |
|
|
P/S
|
Downloadable computer software using Artificial intelligence for use in healthcare, namely, for t... |
|
|
P/S
|
Downloadable artificial intelligence software for healthcare, namely downloadable computer softwa... |
|
|
P/S
|
Artificial intelligence software for healthcare. Medical devices. Provision of research services,... |
|
|
P/S
|
Providing medical information; Providing educational information in the field of immunology diseases |
|
|
Invention
|
Method for filling vials containing liquid drug products.
The invention relates to the pharmaceu... |
|
|
Invention
|
Process for the production of recombinant proteins.
The invention relates to the field of recomb... |
|
|
Invention
|
Antibodies.
The present invention relates to antibodies binding to TREM1 and inhibiting its inte... |
|
|
P/S
|
Downloadable software in the nature of a mobile application for the coordination and management o... |
|
|
Invention
|
Method and system for predicting individualized binary response to a treatment.
A method is prov... |
|
|
P/S
|
Providing medical information in the field of immunology diseases |
|
|
Invention
|
Cell culture processes.
The present invention belongs to the field of the manufacture of recombi... |
|
|
P/S
|
Downloadable virtual goods in the nature of image files of antihistamine and decongestant prepara... |
|
|
P/S
|
Pharmaceutical preparations used for the treatment of neurological disorders, namely epilepsy. |
|
|
P/S
|
Pharmaceuticals in the field of neurology. |
|
|
Invention
|
Formulations comprising a therapeutic protein and at least one stabilizer.
The invention relates... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurological diseases, with the exclusion of pha... |
|
|
Invention
|
Antibodies.
The present invention provides an antibody or antigen-binding fragment thereof that:... |
|
|
P/S
|
mobile apps. medical care and analysis services relating to patient treatment. |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of neurology and immunology diseases |
|
2021
|
Invention
|
Humanised antibodies. CDR-grafted antibody heavy and light chains comprise acceptor framework and... |
